2017 Catalog: All Courses
This webinar is offered through a collaboration with the IHS Division of Diabetes Treatment and Prevention, with the recording available on the DDTP website at https://www.ihs.gov/diabetes/training/cmece-online-edu/diabetes-online-cme-ce-education/. The course is LIVE on 5/10/17 but the recorded session is available until 5/09/2020.
This presentation will provide an overview of the impact of hypoglycemia, the risk factors for hypoglycemia and/or harm from hypoglycemia and what efforts are needed for preventing and treating hypoglycemia in patients on insulin and/or sulfonylureas. The session will include a discussion of the frequency with which hypoglycemia occurs, the risk factors providers need to be aware of, and the morbidity and mortality associated with hypoglycemia. A risk assessment tool for helping assess whether a patient is experiencing hypoglycemia will be provided. Signs, symptoms, and treatment of mild, moderate, and severe hypoglycemia will be addressed. Collaborating with patients to set realistic blood sugar goals to avoid hypoglycemia will also be discussed.
Upon completion of this course, participants will be able to:
1. Outline the signs and symptoms and treatment for mild, moderate and severe hypoglycemia.
2. Describe pharmacologic and non-pharmacologic risk factors for hypoglycemia.
3. Work collaboratively with patients with type 2 diabetes to share in decisions about therapy and treatment goals.
It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.
None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.
Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.